img

Global Prescription Pain Relievers Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Prescription Pain Relievers Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Prescription Pain Relievers Market
Global Prescription Pain Relievers market is expected to reach to US$ 35060 million in 2023, with a positive growth of %, compared with US$ 34290 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Prescription Pain Relievers industry is evaluated to reach US$ 42600 million in 2033. The CAGR will be 3.3% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Prescription Pain Relievers market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Prescription Pain Relievers market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others

Segment by Application


Hospitals
Clinics
Drugstores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Prescription Pain Relievers introduction, etc. Prescription Pain Relievers Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Prescription Pain Relievers
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Pain Relievers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Generic Opioids
1.2.3 Branded Opioids
1.2.4 NSAIDs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prescription Pain Relievers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prescription Pain Relievers Market Perspective (2018-2033)
2.2 Global Prescription Pain Relievers Growth Trends by Region
2.2.1 Prescription Pain Relievers Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Prescription Pain Relievers Historic Market Size by Region (2018-2023)
2.2.3 Prescription Pain Relievers Forecasted Market Size by Region (2024-2033)
2.3 Prescription Pain Relievers Market Dynamics
2.3.1 Prescription Pain Relievers Industry Trends
2.3.2 Prescription Pain Relievers Market Drivers
2.3.3 Prescription Pain Relievers Market Challenges
2.3.4 Prescription Pain Relievers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Prescription Pain Relievers by Players
3.1.1 Global Prescription Pain Relievers Revenue by Players (2018-2023)
3.1.2 Global Prescription Pain Relievers Revenue Market Share by Players (2018-2023)
3.2 Global Prescription Pain Relievers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Prescription Pain Relievers, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Prescription Pain Relievers Market Concentration Ratio
3.4.1 Global Prescription Pain Relievers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Pain Relievers Revenue in 2022
3.5 Global Key Players of Prescription Pain Relievers Head office and Area Served
3.6 Global Key Players of Prescription Pain Relievers, Product and Application
3.7 Global Key Players of Prescription Pain Relievers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Pain Relievers Breakdown Data by Type
4.1 Global Prescription Pain Relievers Historic Market Size by Type (2018-2023)
4.2 Global Prescription Pain Relievers Forecasted Market Size by Type (2024-2033)
5 Prescription Pain Relievers Breakdown Data by Application
5.1 Global Prescription Pain Relievers Historic Market Size by Application (2018-2023)
5.2 Global Prescription Pain Relievers Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Prescription Pain Relievers Market Size (2018-2033)
6.2 North America Prescription Pain Relievers Market Size by Type
6.2.1 North America Prescription Pain Relievers Market Size by Type (2018-2023)
6.2.2 North America Prescription Pain Relievers Market Size by Type (2024-2033)
6.2.3 North America Prescription Pain Relievers Market Share by Type (2018-2033)
6.3 North America Prescription Pain Relievers Market Size by Application
6.3.1 North America Prescription Pain Relievers Market Size by Application (2018-2023)
6.3.2 North America Prescription Pain Relievers Market Size by Application (2024-2033)
6.3.3 North America Prescription Pain Relievers Market Share by Application (2018-2033)
6.4 North America Prescription Pain Relievers Market Size by Country
6.4.1 North America Prescription Pain Relievers Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Prescription Pain Relievers Market Size by Country (2018-2023)
6.4.3 North America Prescription Pain Relievers Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Prescription Pain Relievers Market Size (2018-2033)
7.2 Europe Prescription Pain Relievers Market Size by Type
7.2.1 Europe Prescription Pain Relievers Market Size by Type (2018-2023)
7.2.2 Europe Prescription Pain Relievers Market Size by Type (2024-2033)
7.2.3 Europe Prescription Pain Relievers Market Share by Type (2018-2033)
7.3 Europe Prescription Pain Relievers Market Size by Application
7.3.1 Europe Prescription Pain Relievers Market Size by Application (2018-2023)
7.3.2 Europe Prescription Pain Relievers Market Size by Application (2024-2033)
7.3.3 Europe Prescription Pain Relievers Market Share by Application (2018-2033)
7.4 Europe Prescription Pain Relievers Market Size by Country
7.4.1 Europe Prescription Pain Relievers Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Prescription Pain Relievers Market Size by Country (2018-2023)
7.4.3 Europe Prescription Pain Relievers Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Prescription Pain Relievers Market Size (2018-2033)
8.2 China Prescription Pain Relievers Market Size by Type
8.2.1 China Prescription Pain Relievers Market Size by Type (2018-2023)
8.2.2 China Prescription Pain Relievers Market Size by Type (2024-2033)
8.2.3 China Prescription Pain Relievers Market Share by Type (2018-2033)
8.3 China Prescription Pain Relievers Market Size by Application
8.3.1 China Prescription Pain Relievers Market Size by Application (2018-2023)
8.3.2 China Prescription Pain Relievers Market Size by Application (2024-2033)
8.3.3 China Prescription Pain Relievers Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Prescription Pain Relievers Market Size (2018-2033)
9.2 Asia Prescription Pain Relievers Market Size by Type
9.2.1 Asia Prescription Pain Relievers Market Size by Type (2018-2023)
9.2.2 Asia Prescription Pain Relievers Market Size by Type (2024-2033)
9.2.3 Asia Prescription Pain Relievers Market Share by Type (2018-2033)
9.3 Asia Prescription Pain Relievers Market Size by Application
9.3.1 Asia Prescription Pain Relievers Market Size by Application (2018-2023)
9.3.2 Asia Prescription Pain Relievers Market Size by Application (2024-2033)
9.3.3 Asia Prescription Pain Relievers Market Share by Application (2018-2033)
9.4 Asia Prescription Pain Relievers Market Size by Region
9.4.1 Asia Prescription Pain Relievers Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Prescription Pain Relievers Market Size by Region (2018-2023)
9.4.3 Asia Prescription Pain Relievers Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Type
10.2.1 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Prescription Pain Relievers Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Application
10.3.1 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Prescription Pain Relievers Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Country
10.4.1 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Prescription Pain Relievers Introduction
11.1.4 Pfizer Revenue in Prescription Pain Relievers Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Prescription Pain Relievers Introduction
11.2.4 GSK Revenue in Prescription Pain Relievers Business (2018-2023)
11.2.5 GSK Recent Developments
11.3 Grunenthal
11.3.1 Grunenthal Company Details
11.3.2 Grunenthal Business Overview
11.3.3 Grunenthal Prescription Pain Relievers Introduction
11.3.4 Grunenthal Revenue in Prescription Pain Relievers Business (2018-2023)
11.3.5 Grunenthal Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Prescription Pain Relievers Introduction
11.4.4 Bayer Revenue in Prescription Pain Relievers Business (2018-2023)
11.4.5 Bayer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Prescription Pain Relievers Introduction
11.5.4 Sanofi Revenue in Prescription Pain Relievers Business (2018-2023)
11.5.5 Sanofi Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Prescription Pain Relievers Introduction
11.6.4 Eli Lilly Revenue in Prescription Pain Relievers Business (2018-2023)
11.6.5 Eli Lilly Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Prescription Pain Relievers Introduction
11.7.4 AstraZeneca Revenue in Prescription Pain Relievers Business (2018-2023)
11.7.5 AstraZeneca Recent Developments
11.8 Endo
11.8.1 Endo Company Details
11.8.2 Endo Business Overview
11.8.3 Endo Prescription Pain Relievers Introduction
11.8.4 Endo Revenue in Prescription Pain Relievers Business (2018-2023)
11.8.5 Endo Recent Developments
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Prescription Pain Relievers Introduction
11.9.4 Merck Revenue in Prescription Pain Relievers Business (2018-2023)
11.9.5 Merck Recent Developments
11.10 Depomed
11.10.1 Depomed Company Details
11.10.2 Depomed Business Overview
11.10.3 Depomed Prescription Pain Relievers Introduction
11.10.4 Depomed Revenue in Prescription Pain Relievers Business (2018-2023)
11.10.5 Depomed Recent Developments
11.11 Yunnan Baiyao
11.11.1 Yunnan Baiyao Company Details
11.11.2 Yunnan Baiyao Business Overview
11.11.3 Yunnan Baiyao Prescription Pain Relievers Introduction
11.11.4 Yunnan Baiyao Revenue in Prescription Pain Relievers Business (2018-2023)
11.11.5 Yunnan Baiyao Recent Developments
11.12 Teva
11.12.1 Teva Company Details
11.12.2 Teva Business Overview
11.12.3 Teva Prescription Pain Relievers Introduction
11.12.4 Teva Revenue in Prescription Pain Relievers Business (2018-2023)
11.12.5 Teva Recent Developments
11.13 J&J
11.13.1 J&J Company Details
11.13.2 J&J Business Overview
11.13.3 J&J Prescription Pain Relievers Introduction
11.13.4 J&J Revenue in Prescription Pain Relievers Business (2018-2023)
11.13.5 J&J Recent Developments
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Prescription Pain Relievers Introduction
11.14.4 Allergan Revenue in Prescription Pain Relievers Business (2018-2023)
11.14.5 Allergan Recent Developments
11.15 Purdue
11.15.1 Purdue Company Details
11.15.2 Purdue Business Overview
11.15.3 Purdue Prescription Pain Relievers Introduction
11.15.4 Purdue Revenue in Prescription Pain Relievers Business (2018-2023)
11.15.5 Purdue Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prescription Pain Relievers Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Generic Opioids
Table 3. Key Players of Branded Opioids
Table 4. Key Players of NSAIDs
Table 5. Key Players of Others
Table 6. Global Prescription Pain Relievers Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Prescription Pain Relievers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Prescription Pain Relievers Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prescription Pain Relievers Market Share by Region (2018-2023)
Table 10. Global Prescription Pain Relievers Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Prescription Pain Relievers Market Share by Region (2024-2033)
Table 12. Prescription Pain Relievers Market Trends
Table 13. Prescription Pain Relievers Market Drivers
Table 14. Prescription Pain Relievers Market Challenges
Table 15. Prescription Pain Relievers Market Restraints
Table 16. Global Prescription Pain Relievers Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prescription Pain Relievers Revenue Share by Players (2018-2023)
Table 18. Global Top Prescription Pain Relievers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Relievers as of 2022)
Table 19. Global Prescription Pain Relievers Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Prescription Pain Relievers Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Prescription Pain Relievers, Headquarters and Area Served
Table 22. Global Key Players of Prescription Pain Relievers, Product and Application
Table 23. Global Key Players of Prescription Pain Relievers, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prescription Pain Relievers Revenue Market Share by Type (2018-2023)
Table 27. Global Prescription Pain Relievers Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Prescription Pain Relievers Revenue Market Share by Type (2024-2033)
Table 29. Global Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prescription Pain Relievers Revenue Share by Application (2018-2023)
Table 31. Global Prescription Pain Relievers Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Prescription Pain Relievers Revenue Share by Application (2024-2033)
Table 33. North America Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Prescription Pain Relievers Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Prescription Pain Relievers Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Prescription Pain Relievers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Prescription Pain Relievers Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Prescription Pain Relievers Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Prescription Pain Relievers Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Prescription Pain Relievers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Prescription Pain Relievers Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Prescription Pain Relievers Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Prescription Pain Relievers Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Prescription Pain Relievers Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Prescription Pain Relievers Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Prescription Pain Relievers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Prescription Pain Relievers Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Prescription Pain Relievers Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Prescription Pain Relievers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size by Country (2024-2033) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Prescription Pain Relievers Product
Table 68. Pfizer Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. GSK Company Details
Table 71. GSK Business Overview
Table 72. GSK Prescription Pain Relievers Product
Table 73. GSK Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 74. GSK Recent Developments
Table 75. Grunenthal Company Details
Table 76. Grunenthal Business Overview
Table 77. Grunenthal Prescription Pain Relievers Product
Table 78. Grunenthal Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 79. Grunenthal Recent Developments
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Prescription Pain Relievers Product
Table 83. Bayer Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 84. Bayer Recent Developments
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Prescription Pain Relievers Product
Table 88. Sanofi Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 89. Sanofi Recent Developments
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Prescription Pain Relievers Product
Table 93. Eli Lilly Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 94. Eli Lilly Recent Developments
Table 95. AstraZeneca Company Details
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Prescription Pain Relievers Product
Table 98. AstraZeneca Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 99. AstraZeneca Recent Developments
Table 100. Endo Company Details
Table 101. Endo Business Overview
Table 102. Endo Prescription Pain Relievers Product
Table 103. Endo Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 104. Endo Recent Developments
Table 105. Merck Company Details
Table 106. Merck Business Overview
Table 107. Merck Prescription Pain Relievers Product
Table 108. Merck Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 109. Merck Recent Developments
Table 110. Depomed Company Details
Table 111. Depomed Business Overview
Table 112. Depomed Prescription Pain Relievers Product
Table 113. Depomed Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 114. Depomed Recent Developments
Table 115. Yunnan Baiyao Company Details
Table 116. Yunnan Baiyao Business Overview
Table 117. Yunnan Baiyao Prescription Pain Relievers Product
Table 118. Yunnan Baiyao Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 119. Yunnan Baiyao Recent Developments
Table 120. Teva Company Details
Table 121. Teva Business Overview
Table 122. Teva Prescription Pain Relievers Product
Table 123. Teva Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 124. Teva Recent Developments
Table 125. J&J Company Details
Table 126. J&J Business Overview
Table 127. J&J Prescription Pain Relievers Product
Table 128. J&J Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 129. J&J Recent Developments
Table 130. Allergan Company Details
Table 131. Allergan Business Overview
Table 132. Allergan Prescription Pain Relievers Product
Table 133. Allergan Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 134. Allergan Recent Developments
Table 135. Purdue Company Details
Table 136. Purdue Business Overview
Table 137. Purdue Prescription Pain Relievers Product
Table 138. Purdue Revenue in Prescription Pain Relievers Business (2018-2023) & (US$ Million)
Table 139. Purdue Recent Developments
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prescription Pain Relievers Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Prescription Pain Relievers Market Share by Type: 2022 VS 2033
Figure 3. Generic Opioids Features
Figure 4. Branded Opioids Features
Figure 5. NSAIDs Features
Figure 6. Others Features
Figure 7. Global Prescription Pain Relievers Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Prescription Pain Relievers Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Drugstores Case Studies
Figure 12. Prescription Pain Relievers Report Years Considered
Figure 13. Global Prescription Pain Relievers Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Prescription Pain Relievers Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Prescription Pain Relievers Market Share by Region: 2022 VS 2033
Figure 16. Global Prescription Pain Relievers Market Share by Players in 2022
Figure 17. Global Top Prescription Pain Relievers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Relievers as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Prescription Pain Relievers Revenue in 2022
Figure 19. North America Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Prescription Pain Relievers Market Share by Type (2018-2033)
Figure 21. North America Prescription Pain Relievers Market Share by Application (2018-2033)
Figure 22. North America Prescription Pain Relievers Market Share by Country (2018-2033)
Figure 23. United States Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Prescription Pain Relievers Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Prescription Pain Relievers Market Share by Type (2018-2033)
Figure 27. Europe Prescription Pain Relievers Market Share by Application (2018-2033)
Figure 28. Europe Prescription Pain Relievers Market Share by Country (2018-2033)
Figure 29. Germany Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Prescription Pain Relievers Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Prescription Pain Relievers Market Share by Type (2018-2033)
Figure 37. China Prescription Pain Relievers Market Share by Application (2018-2033)
Figure 38. Asia Prescription Pain Relievers Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Prescription Pain Relievers Market Share by Type (2018-2033)
Figure 40. Asia Prescription Pain Relievers Market Share by Application (2018-2033)
Figure 41. Asia Prescription Pain Relievers Market Share by Region (2018-2033)
Figure 42. Japan Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Prescription Pain Relievers Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Prescription Pain Relievers Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Prescription Pain Relievers Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Prescription Pain Relievers Market Share by Country (2018-2033)
Figure 52. Brazil Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Prescription Pain Relievers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 59. GSK Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 60. Grunenthal Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 61. Bayer Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 63. Eli Lilly Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 64. AstraZeneca Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 65. Endo Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 66. Merck Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 67. Depomed Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 68. Yunnan Baiyao Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 69. Teva Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 70. J&J Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 71. Allergan Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 72. Purdue Revenue Growth Rate in Prescription Pain Relievers Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries